Evidence mapPaperPMID 41023641Full record

ArticleBMC women's health2025

Inflammatory status and clinical phenotypes of PCOS: the role of NLR, SII, SIRI, and AISI.

Halis Doğukan Ozkan, Merve Ayas Ozkan, Ruken Dayanan, Dilara Duygulu Bulan, Ahmet Arif Filiz, Yaprak Engin-Ustun

Abstract read
In one paragraph

Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Halis Doğukan OzkanDepartment of Obstetrics and Gynecology, Ankara Lösante Children and Adult Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-4202-1681
Merve Ayas OzkanDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey. merveayasozkan@gmail.com.ORCID http://orcid.org/0000-0002-2437-9719
Ruken DayananDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-8192-8841
Dilara Duygulu BulanDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0001-9983-2306
Ahmet Arif FilizDepartment of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-6137-0270
Yaprak Engin-UstunDepartment of Obstetric and Gynecology, Ankara City Hospital, Ankara, 06170, Turkey.ORCID http://orcid.org/0000-0002-1011-3848

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolycystic ovary syndrome (PCOS) is a common endocrine-metabolic disorder in women of reproductive age, often associated with low-grade chronic inflammation. This study aimed to investigate the relationship between composite inflammatory markers-Neutrophil-to-Lymphocyte Ratio (NLR), Systemic Immune Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Aggregate Index of Systemic Inflammation (AISI)-and clinical phenotypes of PCOS, including oligo-/amenorrhea, hyperandrogenism, and polycystic ovarian morphology (PCOM).

methodsIn this retrospective cross-sectional study, women with PCOS were categorized into subgroups based on clinical phenotypes. Composite inflammatory markers were calculated from complete blood count parameters, and their association with clinical, hormonal, and ultrasonographic findings was analyzed. ROC analysis assessed the discriminatory value of each marker.

resultsInflammatory markers were significantly higher in the oligo-/amenorrhea and PCOM groups. In oligo-/amenorrhea, NLR (2.42 vs. 1.96, p = 0.028), AISI (282.16 vs. 188.73, p = 0.005), SII (664.59 vs. 519.86, p = 0.008), and SIRI (0.97 vs. 0.70, p = 0.005) were elevated. In PCOM, NLR (2.85 vs. 2.25, p = 0.025), AISI (323.15 vs. 262.78, p = 0.049), SII (738.52 vs. 641.27, p = 0.030), and SIRI (1.10 vs. 0.90, p = 0.046) were also higher. AISI showed the best discrimination for oligo-/amenorrhea (AUC = 0.652), while NLR was most predictive for PCOM (AUC = 0.617).

conclusionsComposite inflammatory markers are elevated in specific PCOS phenotypes, especially oligo-/amenorrhea and PCOM, and may reflect low-grade inflammation. These markers may help identify patients at higher cardiometabolic risk and guide preventive strategies.

Indexed as

InflammationLymphocytesNeutrophilsPolycystic Ovary SyndromeAdultBiomarkersCross-Sectional StudiesFemaleHumansHyperandrogenismPhenotypeRetrospective StudiesYoung AdultBiomarkersBiomarkersChronic diseaseInflammationPolycystic ovary syndrome

Identifiers

PMID41023641
PMCPMC12481869

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.